Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Account Payables (2020 - 2025)

BioScience Health Innovations has reported Change in Account Payables over the past 6 years, most recently at -$3891.0 for Q4 2025.

  • Quarterly Change in Account Payables fell 1660.63% to -$3891.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1952.0 through Dec 2025, down 454.26% year-over-year, with the annual reading at -$1952.0 for FY2025, 454.26% down from the prior year.
  • Change in Account Payables was -$3891.0 for Q4 2025 at BioScience Health Innovations, up from -$6471.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $8189.0 in Q1 2025 and troughed at -$14334.0 in Q2 2023.
  • The 5-year median for Change in Account Payables is $728.5 (2021), against an average of -$153.25.
  • The largest YoY upside for Change in Account Payables was 337.91% in 2025 against a maximum downside of 1660.63% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $3909.0 in 2021, then tumbled by 74.24% to $1007.0 in 2022, then plummeted by 332.67% to -$2343.0 in 2023, then skyrocketed by 90.57% to -$221.0 in 2024, then crashed by 1660.63% to -$3891.0 in 2025.
  • Per Business Quant, the three most recent readings for BHIC's Change in Account Payables are -$3891.0 (Q4 2025), -$6471.0 (Q3 2025), and $221.0 (Q2 2025).